Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1782223 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD)
Last $2.87Day −1.71%Mkt cap $182M1Y +149.6%Off 52W high −48.3%Vol (1Y) 125.3%
Split-adj closes · 240 of 1,200 · price rtn
| Short interest5.1% of sh out |
| Days to cover3.1d |
| 13F net flow (QoQ)−4.26% |
| Top-10 13F concentration84.0% |
| Next report (est.)2026-08-12 |
SI 2026-07-15 · 13F 2026-Q1
| Sales (TTM)$13.9M |
| Earnings (TTM)-$81.7M |
| ROE−91.4% |
| Net margin−574.5% |
| ROIC−95.8% |
FY ratios · TTM sales/earnings (USD)
| YTD+149.6% |
| 1Y+149.6% |
| 3Y+11.2% |
| Since incept. (ann.)−25.8% |
Total return · from 2021-10-11
| Ann. volatility (1Y)125.3% |
| Ann. volatility (3Y)104.0% |
| Sharpe (1Y)1.41 |
| Sharpe (3Y)0.57 |
| Max drawdown (1Y)−80.1% |
| Max drawdown (3Y)−86.7% |
| Beta (3Y vs SPY)1.20 |
Daily returns, ann.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Pfizer Inc | 7.0M | $9M | 11.19% | +0.0% |
| Laurion Capital Management LP | 5.0M | $7M | 7.95% | +4.2% |
| GordonMD Global Investments LP | 4.1M | $6M | 6.56% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $3M | 3.24% | new |
| Atle Fund Management AB | 197,036 | $2M | 0.31% | −68.1% |
| Palo Alto Investors LP | 1.0M | $1M | 1.61% | −2.6% |
| 683 Capital Management, LLC | 896,263 | $1M | 1.43% | +0.5% |
| RENAISSANCE TECHNOLOGIES LLC | 888,680 | $1M | 1.41% | +22.0% |
Δ vs 2025-Q4
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.37 | — | — | — |
| 2025-09-30 | 2025-11-03 | −$0.35 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$0.30 | — | $2.8M | — |
| 2025-03-31 | 2025-05-15 | −$0.35 | — | — | — |
As-reported XBRL · next 2026-08-12 est.
Sale Of Royalty Rights 80% · Milestone Revenue 20%
product & service · TAGGED revenue
